Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors
- PMID: 16149059
- DOI: 10.1002/jcb.20600
Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors
Abstract
PSGR is a newly identified human prostate tissue-specific gene belonging to the G-protein coupled receptor (GPCR) family. Overexpression of PSGR is associated with human prostate intraepithelial neoplasia (PIN) and prostate tumors, suggesting PSGR may play an important role in early prostate cancer development and progression. To understand the regulation of tissue-specific expression of human PSGR and its upregulation mechanism in prostate cancers, we characterized the promoter region of PSGR and analyzed the control mechanism for PSGR expression in human prostate tissues/cells. In this report, we demonstrate that two distinct promoters control the transcriptional regulation of PSGR in human prostate cells. The first promoter region includes exon 1 and a TATA box at -31 site. The minimal DNA sequence with promoter activity is about 123 bp upstream of exon 1. Exon 1 contains tissue specific regulatory activity for the first promoter of PSGR gene. The second promoter is located in the upstream region of exon 2, which is a TATA-less and non-GC-rich promoter. Primer extension and RNA protection assays (RPA) revealed that the transcription driven by the second promoter is initiated at the junction of intron and exon 2 within a cluster of nucleotides located about 250 bp upstream from the junction. Both promoters show prostate cell-specific characteristics in our luciferase assays in transfected cells. Furthermore, we investigated the regulation of the promoter activities of the PSGR gene by different growth factors and cytokines, and demonstrated that interleukin-6 (IL-6) activates the promoter activities of PSGR in human prostate cancer cells. These data suggest that two functional promoters regulate the transcriptional expression of PSGR in human prostate tissues and PSGR is a new target for IL-6 transcriptional regulation.
2005 Wiley-Liss, Inc.
Similar articles
-
PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.Cancer Res. 2000 Dec 1;60(23):6568-72. Cancer Res. 2000. PMID: 11118034
-
Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.Gene. 2005 Nov 21;361:89-100. doi: 10.1016/j.gene.2005.07.012. Epub 2005 Sep 21. Gene. 2005. PMID: 16181749
-
The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.Gene. 2005 Apr 25;350(1):65-77. doi: 10.1016/j.gene.2005.02.004. Gene. 2005. PMID: 15792532
-
Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.J Steroid Biochem Mol Biol. 2005 May;95(1-5):17-23. doi: 10.1016/j.jsbmb.2005.04.002. J Steroid Biochem Mol Biol. 2005. PMID: 15955695 Review.
-
Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):273-80. J Steroid Biochem Mol Biol. 1997. PMID: 9365201 Review.
Cited by
-
Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy.PLoS One. 2013;8(2):e56730. doi: 10.1371/journal.pone.0056730. Epub 2013 Feb 21. PLoS One. 2013. PMID: 23437226 Free PMC article.
-
Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.PLoS One. 2012;7(9):e45756. doi: 10.1371/journal.pone.0045756. Epub 2012 Sep 20. PLoS One. 2012. PMID: 23029225 Free PMC article.
-
Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.Oncogene. 2016 Mar 3;35(9):1153-62. doi: 10.1038/onc.2015.170. Epub 2015 Jun 1. Oncogene. 2016. PMID: 26028029 Free PMC article.
-
Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.Neoplasia. 2013 Jul;15(7):720-6. doi: 10.1593/neo.13232. Neoplasia. 2013. PMID: 23814484 Free PMC article.
-
The olfactory receptor OR51E2 regulates prostate cancer aggressiveness and modulates STAT3 in prostate cancer cells and in xenograft tumors.BMC Cancer. 2025 Mar 24;25(1):535. doi: 10.1186/s12885-025-13928-0. BMC Cancer. 2025. PMID: 40128715 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous